(1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester CAS:907196-12-7

In pharmaceutical synthesis, (1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester plays a significant role in the asymmetric synthesis of chiral drugs and bioactive compounds. As a chiral auxiliary or catalyst precursor, it enables the stereoselective construction of complex molecular frameworks, enhancing the pharmacological properties and therapeutic efficacy of drug candidates. Its incorporation into molecular structures facilitates the modulation of biological targets, leading to the discovery of novel treatments for various diseases, including cancer, cardiovascular disorders, and central nervous system ailments. Moreover, this compound finds applications in chemical research for the development of asymmetric synthesis methodologies and stereoselective transformations. Its chiral nature allows for the preparation of enantiomerically pure intermediates, essential for the synthesis of fine chemicals, agrochemicals, and specialty materials. Additionally, it serves as a key component in the fabrication of chiral ligands and catalysts employed in asymmetric catalysis, facilitating efficient and environmentally friendly synthetic routes to complex molecules. Overall, the versatile applications of (1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester underscore its significance as a valuable chiral compound in pharmaceutical synthesis and chemical research, driving advancements in drug discovery, molecular design, and synthetic methodologies.